Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec 31:8:27.
doi: 10.1186/1744-859X-8-27.

Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis

Konstantinos N Fountoulakis  1 , Xenia Gonda, Eduard Vieta, Frank Schmidt
Affiliations

Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis

Konstantinos N Fountoulakis et al. Ann Gen Psychiatry. .

Abstract

Background: We present a systematic review and meta-analysis of the available clinical trials concerning the usefulness of aripiprazole in the treatment of the psychotic symptoms in bipolar disorder.

Methods: A systematic MEDLINE and repository search concerning clinical trials for aripiprazole in bipolar disorder was conducted.

Results: The meta-analysis of four randomised controlled trials (RCTs) on acute mania suggests that the effect size of aripiprazole versus placebo was equal to 0.14 but a more reliable and accurate estimation is 0.18 for the total Positive and Negative Syndrome Scale (PANSS) score. The effect was higher for the PANSS-positive subscale (0.28), PANSS-hostility subscale (0.24) and PANSS-cognitive subscale (0.20), and lower for the PANSS-negative subscale (0.12). No data on the depressive phase of bipolar illness exist, while there are some data in favour of aripiprazole concerning the maintenance phase, where at week 26 all except the total PANSS score showed a significant superiority of aripiprazole over placebo (d = 0.28 for positive, d = 0.38 for the cognitive and d = 0.71 for the hostility subscales) and at week 100 the results were similar (d = 0.42, 0.63 and 0.48, respectively).

Conclusion: The data analysed for the current study support the usefulness of aripiprazole against psychotic symptoms during the acute manic and maintenance phases of bipolar illness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Forest plot of aripiprazole effect size against psychotic symptoms in acute mania (PANSS-total data).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fountoulakis KN, Grunze H, Panagiotidis P, Kaprinis G. Treatment of bipolar depression: an update. J Affect Disord. 2008;109(1-2):21–34. doi: 10.1016/j.jad.2007.10.016. - DOI - PubMed
    1. Fountoulakis KN, Magiria S, Siamouli M, Panagiotidis P, Nimatoudis I, Iacovides A, Kaprinis GS. A seven- year follow-up of an extremely refractory bipolar I patient. CNS spectrums. 2007;12(10):733–734. - PubMed
    1. Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord. 2005;86(1):1–10. doi: 10.1016/j.jad.2005.01.004. - DOI - PubMed
    1. Fountoulakis KN, Vieta E, Siamouli M, Valenti M, Magiria S, Oral T, Fresno D, Giannakopoulos P, Kaprinis GS. Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder. Ann Gen Psychiatry. 2007;6:27. doi: 10.1186/1744-859X-6-27. - DOI - PMC - PubMed
    1. Fountoulakis KN. The contemporary face of bipolar illness: complex diagnostic and therapeutic challenges. CNS spectrums. 2008;13(9):763–774. - PubMed

LinkOut - more resources